Extracorporeal membrane oxygenation versus invasive ventilation in patients with COVID‐19 acute respiratory distress syndrome and pneumomediastinum: A cohort trial.

MLA

Attou, Rachid, et al. “Extracorporeal Membrane Oxygenation versus Invasive Ventilation in Patients with COVID‐19 Acute Respiratory Distress Syndrome and Pneumomediastinum: A Cohort Trial.” Artificial Organs, vol. 48, no. 9, Sept. 2024, pp. 1038–48. EBSCOhost, https://doi.org/10.1111/aor.14760.

APA

Attou, R., Redant, S., Velissaris, D., Kefer, K., Abou, L. M., Waterplas, E., & Pierrakos, C. (2024). Extracorporeal membrane oxygenation versus invasive ventilation in patients with COVID‐19 acute respiratory distress syndrome and pneumomediastinum: A cohort trial. Artificial Organs, 48(9), 1038–1048. https://doi.org/10.1111/aor.14760

Chicago

Attou, Rachid, Sebastien Redant, Dimitrios Velissaris, Keitiane Kefer, Lebdeh, Mazen Abou, Eric Waterplas, and Charalampos Pierrakos. 2024. “Extracorporeal Membrane Oxygenation versus Invasive Ventilation in Patients with COVID‐19 Acute Respiratory Distress Syndrome and Pneumomediastinum: A Cohort Trial.” Artificial Organs 48 (9): 1038–48. doi:10.1111/aor.14760.